Cumberbatch, E. P. and C. A. Robinson (1925). Treatment of gonococcal infection by diathermy: (with an appendix on the treatment of other forms of arthritis by diathermy). London, William Heinemann, ltd.
|
Cummins, C. and H. T. A. National Co-ordinating Centre for (2002). A systematic review of the effectiveness and economic evaluation of new drug treatments for juvenile idiopathic arthritis: etanercept. Alton, Core Research on behalf of the NCCHTA.
|
Cummins, C., H. T. A. National Co-ordinating Centre for, et al. (2002). A systematic review of effectiveness and economic evaluation of new drug treatments for juvenile idiopathic arthritis: etanercept. Southampton, National Coordinating Centre for Health Technology Assessment.
|
Cunningham-Boothe, A. (1993). One man's look at arthritis. Royal Leamington Spa, Korvet.
|
Current Drugs, L. (1997). Rheumatoid arthritis: ID research alert. London, Current Drugs Ltd.
|
Current Drugs, L. (1998). Current research in rheumatoid arthritis. London, Current Drugs.
|
Currey (1977). Investigations of a patient with arthritis. London, Graves Medical Audiovisual Library: 34slides.
|
Currey, H. L. F. (1970). Investigation of a patient with arthritis. Chelmsford, Graves Medical Audiovisual Lib.
|
Currey, H. L. F. (1983). Essentials of rheuatology. Edinburgh, Churchill Livingstone.
|
Currey, H. L. F. (1986). Essentials of rheumatology. Edinburgh, Churchill Livingstone.
|
Currey, H. L. F. and S. Hull (1987). Rheumatology for general practitioners. Oxford; New York, Oxford University Press.
|
Currey, H. L. F., C. F. Hawkins, et al. (1972). Reports on rheumatic diseases: collected reports 1959-1971. London, Arthritis and Rheumatism Council for Research.
|
Cush, J. J. (1999). Rheumatology: diagnosis and therapeutics. Baltimore; London, Williams & Wilkins.
|
Cutolo, M., D. International Conference on the Neuroendocrine Immune Basis of the Rheumatic, et al. (2002). Neuroendocrine immune basis of the rheumatic diseases II: proceedings of the second international conference. New York, N.Y., New York Academy of Sciences.
|
Cuturi, M. C. (1996). Role of peptides in allorecognition. Copenhagen, Munksgaard.
|
Cyriax, J. H. (1956). Hydrocortisone in orthopaedic medicine. London, Cassell.
|
Dahlqvist, S. R. and u. Umeå (1986). Genetic markers in rheumatoid arthritis. Stockholm, Distributed by the Almqvist & Wiksell Periodical Company.
|
Dale, M. (2001). Mapping and genetic analysis of the Interleukin-1-receptor gene cluster in rheumatoid arthritis.
|
Dalziel, M. (2002). Regulation of peripheral blood B lymphocytic and serum CMP-Neu5AC: Gglybl, 4GlcNAC-a2,6 sialyltransferase activity in relation to serum immunoglobulinG a2,6 sialylation in rheumatoid arthritis: 273 leaves.
|
Dalziel, M. and L. University of (2002). Regulation of peripheral blood B-lymphocytic and serum CMP-NeuSAC: Galbl, 4GlcNAc - 'alpha'2,6 sialyltransferase activity in relation to serum polyclonal immunoglobulin G 'alpha'2,6 sialylation in rheumatoid arthritis.
|
Daniel Peter, L. (1912). Arthritis. A study of the inflamatory diseases of joints. Edited by James Cantlie. London, John Bale, Sons & Danielsson.
|
Daniel, P. and J. S. Cantlie (1911). Arthritis; a study of the inflammatory diseases of joints. London, Bale & Danielsson.
|
Daniels, R. H. (1991). The role of complement in the pathogenesis of theurmatoid arthritis.
|
Danks, L. and O. University of (2004). The effect of inflammatory cells and humoral factors on osteoclast differentiation in rheumatoid arthritis and other joint conditions. Oxford, University of Oxford.
|
Danneskiold-Samsøe, B. (1987). Muscle function in women with rheumatoid arthritis: the influence of glucocorticosteroids. Copenhagen, Laegeforeningens Forlag.
|
Darlington, G. and L. Gamlin (1996). Diet and arthritis: a comprehensive guide to treating arthritis through diet. London, Vermilion.
|
Das, P. C. (1983). Synovectomy of the knee in the management of rheumatoid arthritis.
|
Dasari, B. D. (1989). The effect of hand position and grip size in patients with rheumatoid arthritis: a biomechanical study, Original typescript.
|
Datamonitor (2001). Drugs of tomorrow 2000: arthritis. New York; London, Datamonitor.
|
Dauphin, S. (1988). Sjogren's syndrome: the sneaky "arthritis", Pixel Press.
|
David, C. and J. Lloyd (1998). Rheumatological physiotherapy. London, Mosby.
|
Davies, D., A. Cahn, et al. (1995). [Arthritis]. The pulse. [s.l.], Diverse Productions in association with XYTV for Channel Four Television.
|
Davies, G. H. (1997). Lighten our arthritic darkness: you don't have to live with it. Taunton, Nirvana.
|
Davies, M. E. and J. T. Dingle (1994). Immunopharmacology of joints and connective tissue. London; San Diego, Academic Press.
|
Davies, N. W. (1921). Rheumatoid arthritis: the lesson of twenty five years' experience: extr. from "The Practitioner" Dec. 1921. [S.l.], [The Practitioner].
|
Davis, M. M., J. Buxbaum, et al. (1995). T-cell receptor use in human autoimmune diseases. New York, N.Y., New York Academy of Sciences.
|
Davis, P. and M. Harth (1982). Therapeutic innovation in rheumatoid arthritis: worldwide auranofin symposium, Montreal, Canada, October 20-21, 1981: proceedings. Toronto, On., The Journal of Rheumatology.
|
Dawood, F. H. (1985). The role of HLA class II antigens (HLA-DR) in arthritis (juvenile onset and rheumatoid).
|
Day, R. O. (2005). Antirheumatic therapy: actions and outcomes. Basel, Birkhauser Verlag.
|
De Broe, S., P. Hewitson, et al. (1999). Leflunomide: a new disease modifying drug for rheumatoid arthritis. [Southampton], Wessex Institute for Health Research and Development.
|